This study demonstrates that DDAH1 is frequently downregulated in clinical GC samples and its low expression is closely associated with more lymph node metastasis, lower histological differentiation, and poorer clinical outcome. This evidence concerns the gene DDAH1 and metastatic malignant neoplasm in the lymph nodes.